FDA Approves New CRISPR Treatments for Sickle Cell Disease, But Affordability and Access Remain in Doubt
On Friday, the US Food and Drug Administration approved gene-based treatments for sickle cell disease, including the first CRISPR based ...
On Friday, the US Food and Drug Administration approved gene-based treatments for sickle cell disease, including the first CRISPR based ...